MedTrace Logo

Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies

NCT00865540 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-05-24

No results posted yet for this study

Summary

The main objective of this study is to compare the effect of preoperative use of anti-inflammatory topical prednisolone acetate 1%, nepafenac 0.1% and ketorolac tromethamine 0.4% of, plus a placebo, in maintaining the intra-operative mydriasis in extraction.

Conditions

  • Cataract

Interventions

DRUG

prednisolone acetate 1%

1 drop every 8h two days before surgery

DRUG

ketorolac tromethamine 0.4%

1 drop every 8h two days before surgery

DRUG

nepafenac 0.1%

1 drop every 8h two days before surgery

DRUG

methylcellulose 0.5%

1 drop every 8h two days before surgery

Sponsors & Collaborators

  • Clinica Oftamologica Zona Sul

    lead OTHER

Principal Investigators

  • Alexandre P Costa, Pinto · Clínica Oftalmológica Zona Sul

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00865540 on ClinicalTrials.gov